Key Events This Week
2 Feb: Bearish momentum intensifies with 3.28% drop to Rs.614.85
3 Feb: Intraday high of Rs.718.55 reached after 8.38% surge
5 Feb: Technical momentum shifts to mildly bearish amid mixed signals
6 Feb: Downgrade to Strong Sell; stock closes at Rs.614.35 (-1.79%)
2 February 2026: Bearish Momentum Deepens
Jubilant Ingrevia began the week under pressure, closing at Rs.614.85, down 3.28% from the prior close of Rs.635.70. This decline was sharper than the Sensex’s 1.03% drop to 35,814.09, signalling intensified selling pressure. Technical indicators such as MACD and moving averages confirmed a shift to a pronounced bearish trend, with the stock trading closer to its 52-week low of Rs.556.55. Momentum oscillators and Bollinger Bands suggested heightened volatility and downside risk, while the Relative Strength Index (RSI) remained neutral, indicating no immediate oversold condition. The technical deterioration reflected both sectoral headwinds and company-specific challenges.
3 February 2026: Strong Gap-Up Rally and Intraday High
In a striking reversal, Jubilant Ingrevia surged 8.38% to close at Rs.666.35, after opening with a significant gap up of 16.87%. The stock reached an intraday high of Rs.718.55, outperforming the Pharmaceuticals & Drugs sector’s 2.92% gain and the Sensex’s 2.63% rise. This rally was driven by strong buying interest and short-term momentum, with the price closing above the 5-day moving average. However, the stock remained below longer-term averages, indicating resistance ahead. Intraday volatility was elevated at 6.86%, reflecting active trading and profit-taking. Despite the positive price action, MarketsMOJO maintained a cautious stance, retaining a Sell rating due to mixed technical and fundamental signals.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
4 February 2026: Consolidation and Minor Pullback
The stock retraced slightly on 4 February, closing at Rs.654.50, down 1.78% from the previous day’s close. This pullback occurred despite the Sensex advancing 0.37% to 36,890.21, indicating some profit-taking after the prior day’s sharp gains. Technical indicators remained mixed, with the stock still below key medium- and long-term moving averages. The intraday range of Rs.667.00 to Rs.643.00 reflected moderate volatility. The consolidation phase suggested investors were digesting the recent rally amid ongoing uncertainty about the stock’s medium-term direction.
5 February 2026: Technical Momentum Shifts to Mildly Bearish
On 5 February, Jubilant Ingrevia’s price declined 4.42% to Rs.625.55, accompanied by a volume surge to 22,951 shares. Technical momentum indicators showed a nuanced shift from outright bearishness to a mildly bearish stance. The weekly RSI turned bullish, hinting at potential short-term strength, while the MACD remained bearish on the weekly chart but softened on the monthly timeframe. Bollinger Bands suggested a slight downward bias with reduced volatility on the monthly scale. Despite the price drop, the stock remained above its 52-week low, indicating some resilience. The mixed signals reflected a transitional phase, with investors cautious amid sectoral headwinds and company-specific challenges.
6 February 2026: Downgrade to Strong Sell Amid Intensified Bearish Momentum
The week concluded with a further decline to Rs.614.35, down 1.79% on the day and 3.36% for the week. MarketsMOJO downgraded Jubilant Ingrevia from Sell to Strong Sell, citing deteriorating financial performance and worsening technical indicators. The company’s December 2025 quarter showed a 21.9% drop in PAT to Rs.56.25 crores and margin pressures with operating profit to net sales ratio falling to 12.04%. Technical indicators such as MACD, moving averages, Bollinger Bands, and the Know Sure Thing (KST) indicator all signalled sustained bearish momentum. The stock’s Mojo Score declined to 28.0, reflecting heightened risk. Despite an attractive valuation with a PE ratio of 36.25 and a PEG of 1.09, the fundamental weaknesses and technical downtrend overshadowed valuation appeal.
Considering Jubilant Ingrevia Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
Daily Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-02 | Rs.614.85 | -3.28% | 35,814.09 | -1.03% |
| 2026-02-03 | Rs.666.35 | +8.38% | 36,755.96 | +2.63% |
| 2026-02-04 | Rs.654.50 | -1.78% | 36,890.21 | +0.37% |
| 2026-02-05 | Rs.625.55 | -4.42% | 36,695.11 | -0.53% |
| 2026-02-06 | Rs.614.35 | -1.79% | 36,730.20 | +0.10% |
Key Takeaways
Positive Signals: The strong gap-up rally on 3 February demonstrated the stock’s capacity for sharp short-term gains, outperforming both sector peers and the Sensex. The weekly RSI and KST indicators on 5 February hinted at emerging short-term strength, suggesting potential for technical rebounds.
Cautionary Signals: Despite intermittent rallies, the overall technical momentum remains bearish, with daily moving averages, MACD, and Bollinger Bands signalling sustained selling pressure. The downgrade to Strong Sell by MarketsMOJO reflects deteriorating financial metrics, including a 21.9% PAT decline and margin compression. The stock’s consistent underperformance relative to the Sensex over multiple timeframes underscores ongoing challenges.
Valuation and Market Position: While valuation metrics such as PE and PEG ratios appear reasonable, they are insufficient to offset fundamental weaknesses and technical downtrends. The company’s mid-tier market capitalisation and sector-specific headwinds further complicate the outlook.
Conclusion
Jubilant Ingrevia Ltd’s week was marked by volatility and mixed signals, culminating in a 3.36% weekly decline against a 1.51% gain in the Sensex. The stock’s sharp intraday rally on 3 February was offset by subsequent declines and a significant downgrade to Strong Sell, reflecting deteriorating financial performance and intensifying bearish technical momentum. Investors should remain cautious, monitoring key support levels near the 52-week low and awaiting clearer signs of trend reversal. The combination of fundamental challenges and technical weakness suggests that Jubilant Ingrevia faces a difficult near-term outlook within the specialty chemicals sector.
Unlock special upgrade rates for a limited period. Start Saving Now →
